Loblaw Companies Limited · TSX:L
Loblaw Companies — Q3 2016 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, Nov 16, 2016
Slide 1: Q3 2016 Supplementary Slides
Q3 2016 Supplementary Slides November 16, 2016 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Loblaw – Q3 2016
Key Financial Metrics – Loblaw – Q3 2016 Consolidated Revenue $ 14,143M +1.4% Adjusted EBITDA and Margin $ 1,143M +11.8% +8.1% +80bps Adjusted Diluted Earnings Per Common +28.6% $ 1.26 Share Free Cash Flow $ 564M QTD (2015 $578M) Capex ($) $ 383M QTD (2015 $356M) 3
Slide 4: Key Retail Metrics – Q3 2016
Key Retail Metrics – Q3 2016 Total Retail Revenue $ 13,891M +1.3% Retail Revenue - Food Retail $ 10,278M +1.0% Retail Revenue - Drug Retail $ 3,613M +2.1% $ 3,594M 26.1% +30bps Retail Adjusted Gross Profit & Margin (Excluding the impact of the consolidation of franchises) (As Reported: $3,714 millio
Slide 5: Key Operational Metrics – Q3 2016 – Loblaw
Key Operational Metrics–Q3 2016—Loblaw +1.4% (gas bar -60bps); including impact of gas bar food Food Retail Same-Store Sales Growth retail comp SSS was +0.8% Basket Size Traffic Internal Food Price Index Declined and is lower than CPI of 0.2% Loblaw STM Square Footage Growth Industry STM Square Foot
Slide 6: Key Operational Metrics – Q3 2016
Key Operational Metrics – Q3 2016 Shoppers Drug Mart Pharmacy Sales $ 1,732M +1.9% (2015 +3.6%) Pharmacy SSS +1.6% (2015 +3.5%) # Rx Dispensed (Rx Count-Absolute) +2.9% (2015 +4.2%) +2.6% (2015 +4.4%) Average Rx Value -0.8% (2015 -0.2%) Front of Store Sales $ 1,881M +2.3% (2015 +5.2%) Front of Store